Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(9%)
Results Posted
13%(1 trials)

Phase Distribution

Ph early_phase_1
1
9%
Ph not_applicable
8
73%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(8)
Other(1)

Detailed Status

Completed8
Recruiting1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (11.1%)
N/A8 (88.9%)

Trials by Status

completed873%
recruiting19%
not_yet_recruiting19%
unknown19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11